ACUTE GOUTY ARTHRITIS
Clinical trials for ACUTE GOUTY ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE GOUTY ARTHRITIS trials appear
Sign up with your email to follow new studies for ACUTE GOUTY ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New gout drug aims to crush flare pain in 72 hours
Symptom relief Recruiting nowThis study tests a new medicine, punarlimab, for people with acute gouty arthritis (sudden, painful joint flares). About 170 adults who have had at least 3 gout attacks in the past year will receive either punarlimab or an active comparator. The main goal is to see how well punar…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase: PHASE2 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Symptom relief
Last updated May 26, 2026 07:22 UTC
-
New gout pill aims to beat standard treatment in head-to-head pain battle
Symptom relief Recruiting nowThis study tests a new medicine, ABP-745, to see if it reduces pain and swelling from an acute gout flare better than the standard drug colchicine or a placebo. About 380 adults aged 18-70 with frequent gout flares will take one of the three treatments and report their pain level…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC